Article: Venetoclax-rituximab induces deep responses in relapsed CLL

Related products

• 

  Article: Highlights in urologic cancer

  €3.03 Add to cart
• 

  Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

  €3.03 Add to cart
• 

  Article: Highlights in genitourinary cancers

  €3.03 Add to cart
• 

  Article: Highlights in breast cancer

  €3.03 Add to cart